Drugs / GFC CELL EXO SCALP KIT
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06239207 | Sep 2023 → Jul 2024 | androgenetic alopecia | Services Hospital, Lahore | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GFC CELL EXO SCALP KIT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06239207 ↗ |
| Known as | Leuco Exo 97% | “Exosomes GFC CELL EXO SCALP KIT (Leuco Exo 97%)” NCT06239207 ↗ |
| Route | Other | “Group A patients are injected exosomes 2 session 3 months apart, intradermally at a dose of 0.1 ml/cm2 of scalp.” NCT06239207 ↗ |